S'abonner

CT and MRI features of sclerosing angiomatoid nodular transformation of the spleen: A report of 18 patients with pathologic correlation - 26/05/21

Doi : 10.1016/j.diii.2021.01.003 
Jianyong Liao a, 1, Zhanbo Wang b, 1, Qiong Li c, Zhenheng Gou a, Xu Bai d, Huanhuan Kang e, Huaiyin Shi b, Haiyi Wang e,
a Department of Radiology, Daxing Teaching Hospital of Capital Medical University, No. 26 Huangcunxi Street, Daxing District, 102600 Beijing, China 
b Department of Pathology, First Medical Center, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, 100853 Beijing, China 
c Department of Radiology, Tianjin Nankai Hospital, No. 6 Changjiang Road, Nankai District, 300100 Tianjin, China 
d Department of Radiology, Fifth Medical Center, Chinese PLA General Hospital, No. 100 West Fourth Ring Middle Road, Fengtai District, 100039 Beijing, China 
e Department of Radiology, First Medical Center, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, 100853 Beijing, China 

Corresponding author.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Highlights

Sclerosing angiomatoid nodular transformation (SANT) of the spleen mostly presents as a single, solid, splenic mass with central fibrous scar.
Hypointensity on T2- and diffusion-weighted MR images along with signal drop on in-phase images compared to out-of-phase images are typical characteristics of SANT of the spleen possibly corresponding to fibrous tissue and hemosiderin deposition.
The typical enhancement patterns of SANT of the spleen are progressive and centripetal enhancement in association with delayed enhancement of central fibrous scar.

Le texte complet de cet article est disponible en PDF.

Abstract

Purpose

The purpose of this study was to describe the computed tomography (CT) and magnetic resonance imaging (MRI) features of sclerosing angiomatoid nodular transformation (SANT) of the spleen and correlate imaging features with those obtained at histopathologic analysis.

Materials and methods

A total of 18 patients (9 men, 9 women; mean age, 42.2±10.7 [standard deviation (SD)] years; range, 23–59 years) with histopathologically confirmed SANT were retrospectively evaluated. The presenting symptoms, gross pathologic changes, and histopathologic and correlative immunohistochemical results were recorded. CT (n=8) and MRI (n=12) features were analyzed by two radiologists and included number, size, shape, boundary, attenuation, signal intensity, and enhancement patterns.

Results

Seventeen patients (17/18; 94%) had a single SANT without specific clinical symptoms and one patient (1/18; 6%) had multiple SANTs with left-upper-quadrant bloating and pain. The largest lesion diameter exceeded 3cm. On plain CT images, SANTs were slightly hypoattenuating in seven patients (7/8; 88%), isoattenuating in one patient (1/8; 13%), and contained calcification in two patients (2/8; 25%). On T2-weighted MR images, SANTs displayed hypointensity in ten patients (10/12; 83.3%), isointensity in one patient (1/12; 8%) and hyperintensity in one patient (1/12; 8%). On T2-weighted images, stellate or scattered fibrous scars were observed in all patients (12/12; 100%). On diffusion-weighted images, SANTs appeared as heterogenous or homogeneous hypointense in 12 patients (12/12; 100%). Compared to out-of-phase images, SANTs displayed decreased local signal intensity on in-phase images in 12 patients (12/12; 100%). On enhanced CT and MRI images, SANTs had clear boundaries (17/18; 94%), oval (7/18; 39%) or lobular (7/18; 39%) shape, displayed progressive centripetal enhancement (18/18; 100%), spoke-wheel pattern (14/18; 78%), nodular enhancement (11/18; 61%), or delayed enhancement of central fibrous scar (9/18; 50%).

Conclusions

SANT of the spleen predominantly manifests as a solid, single, oval or lobular, and well-defined lesion with a fibrous scar and occasional calcification. Typical enhancement characteristics include progressive and centripetal enhancement, spoke-wheel pattern, nodular enhancement, and delayed enhancement of central fibrous scar. Hypointensity on T2- and diffusion-weighted images are due to hemosiderin deposition and fibrous tissue.

Le texte complet de cet article est disponible en PDF.

Keywords : Magnetic resonance imaging (MRI), Neoplasms, Spleen, Sclerosing angiomatoid nodular transformation (SANT), Tomography, X-ray computed

Abbreviations : 3D-VIBE, CT, DWI, FOV, H&E, MRI, SANT, SD, SMA, TE, TR, T1WI, T2WI


Plan


© 2021  Société française de radiologie. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 102 - N° 6

P. 389-396 - juin 2021 Retour au numéro
Article précédent Article précédent
  • Diagnostic performance of ultra-low dose versus standard dose CT for non-traumatic abdominal emergencies
  • Basien Nicolan, Joël Greffier, Djamel Dabli, Hélène de Forges, Elise Arcis, Nadir Al Zouabi, Ahmed Larbi, Jean-Paul Beregi, Julien Frandon
| Article suivant Article suivant
  • Intestinal intussusception: A rare presentation of Kaposi sarcoma
  • Sara Benchara, Lokmane Taihi, Amandine Pinto, Youcef Guerrache, Valérie Bousson

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.